L834-0523 Screening compound: N-{[3-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-4-fluorobenzene-1-sulfonamide

L834-0523 Screening compound: N-{[3-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-4-fluorobenzene-1-sulfonamide
L834-0523 Screening compound: N-{[3-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-4-fluorobenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L834-0523
N-{[3-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-4-fluorobenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L834-0523

Molecular Formula

C19H17FN4O5S (C19 H17 FN4 O5 S)

Compound Name

N-{[3-(4-ethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-1,2,4-oxadiazol-5-yl]methyl}-4-fluorobenzene-1-sulfonamide

IUPAC name

N-{[3-(4-ethyl-3-oxo-34-dihydro-2H-14-benzoxazin-6-yl)-124-oxadiazol-5-yl]methyl}-4-fluorobenzene-1-sulfonamide

SMILES

CCN1c(cc(cc2)-c3noc(CNS(c(cc4)ccc4F)(=O)=O)n3)c2OCC1=O

InChI

InChI=1S/C19H17FN4O5S/c1-2-24-15-9-12(3-8-16(15)28-11-18(24)25)19-22-17(29-23-19)10-21-30(26,27)14-6-4-13(20)5-7-14/h3-9,21H,2,10-11H2,1H3

InChI Key

JAJFNDOULCLJSH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478852

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

432.43

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.767

Distribution Coefficient, logD

2.695

Water Solubility, LogSw

-3.43

Polar Surface Area

97.166

Acid Dissociation Constant (pKa)

8.14

Base Dissociation Constant (pKb)

-1.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

L834-0523 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L834-0523 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L834-0523?
Check Price and Availability of L834-0523, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L834-0523 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L834-0523
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L834-0523
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L834-0523 available by request